Article thumbnail

Damaged DNA Binding Protein 2 Plays a Role in Breast Cancer Cell Growth

By Zilal Kattan, Sophie Marchal, Emilie Brunner, Carole Ramacci, Agnès Leroux, Jean Louis Merlin, Lionel Domenjoud, Michel Dauça and Philippe Becuwe


The Damaged DNA binding protein 2 (DDB2), is involved in nucleotide excision repair as well as in other biological processes in normal cells, including transcription and cell cycle regulation. Loss of DDB2 function may be related to tumor susceptibility. However, hypothesis of this study was that DDB2 could play a role in breast cancer cell growth, resulting in its well known interaction with the proliferative marker E2F1 in breast neoplasia. DDB2 gene was overexpressed in estrogen receptor (ER)-positive (MCF-7 and T47D), but not in ER-negative breast cancer (MDA-MB231 and SKBR3) or normal mammary epithelial cell lines. In addition, DDB2 expression was significantly (3.0-fold) higher in ER-positive than in ER-negative tumor samples (P = 0.0208) from 16 patients with breast carcinoma. Knockdown of DDB2 by small interfering RNA in MCF-7 cells caused a decrease in cancer cell growth and colony formation. Inversely, introduction of the DDB2 gene into MDA-MB231 cells stimulated growth and colony formation. Cell cycle distribution and 5 Bromodeoxyuridine incorporation by flow cytometry analysis showed that the growth-inhibiting effect of DDB2 knockdown was the consequence of a delayed G1/S transition and a slowed progression through the S phase of MCF-7 cells. These results were supported by a strong decrease in the expression of S phase markers (Proliferating Cell Nuclear Antigen, cyclin E and dihydrofolate reductase). These findings demonstrate for the first time that DDB2 can play a role as oncogene and may become a promising candidate as a predictive marker in breast cancer

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2003). Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements.
  2. (2003). BRCA-1 and p53: compensatory roles in DNA repair.
  3. (2002). BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair.
  4. (2002). BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation.
  5. (1993). Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E.
  6. (1995). Chromosomal localization and cDNA cloning of the genes (DDB1 and DDB2) for the p127 and p48 subunits of a human damage-specific DNA binding protein.
  7. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
  8. (1999). Cullin 4A associates with the UVdamaged DNA-binding protein DDB.
  9. (1998). DDB, a putative DNA repair protein, can function as a transcriptional partner of E2F1.
  10. (2007). Ddb2 is a haploinsufficient tumor suppressor and controls spontaneous germ cell apoptosis.
  11. (1997). Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
  12. (1997). Distinct roles for E2F proteins in cell growth control and apoptosis.
  13. (1977). DNA sequencing with chainterminating inhibitors.
  14. (2000). E2F-1: a proliferative marker of breast neoplasia.
  15. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
  16. (2005). Enhanced DDB2 expression protects mice from carcinogenic effects of chronic UV-B irradiation.
  17. (2002). G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity.
  18. (2000). Human damage-specific DNA-binding protein p48. Characterization of XPE mutations and regulation following UV irradiation.
  19. (2004). Human DDB2 splicing variants are dominant negative inhibitors of UV-damaged DNA repair.
  20. (2001). Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo.
  21. (2003). Impaired regulation of tumor suppressor p53 caused by mutations in the xeroderma pigmentosum DDB2 gene: mutual regulatory interactions between p48(DDB2) and p53.
  22. (1994). Isolation of nuclear extracts from fragile cells: a simplified procedure applied to thymocytes.
  23. La Thangue NB (2004) The emerging role of E2F-1 in the DNA damage response and checkpoint control.
  24. (1996). Mutations specific to the xeroderma pigmentosum group E Ddb- phenotype.
  25. (2002). Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells.
  26. (1994). Oncogenic capacity of the E2F1 gene.
  27. (1998). p48 Activates a UV-damagedDNA binding factor and is defective in xeroderma pigmentosum group E cells that lack binding activity.
  28. (2002). p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice.
  29. (1992). Peroxisomal enzymes in normal and tumoral human breast.
  30. (2006). Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study.
  31. (1951). Protein measurement with the Folin phenol reagent.
  32. (2007). Role of manganese superoxide dismutase on growth and invasive properties of human estrogenindependent breast cancer cells. Breast Cancer Res Treat.
  33. (2005). Sancar A
  34. (2001). The p48 subunit of the damaged-DNA binding protein DDB associates with the CBP/p300 family of histone acetyltransferase.
  35. (2005). The UVdamaged DNA binding protein mediates efficient targeting of the nucleotide excision repair complex to UV-induced photo lesions.
  36. (2001). The xeroderma pigmentosum group E gene product DDB2 is a specific target of cullin 4A in mammalian cells.
  37. (2005). Tumorprone phenotype of the DDB2-deficient mice.
  38. (2001). UV-damaged DNA-binding proteins are targets of CUL-4A-mediated ubiquitination and degradation.
  39. (1994). Xeroderma pigmentosum group E binding factor recognizes a broad spectrum of DNA damage.
  40. (1988). Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA.